Eli Lilly transfers commercialization rights for breast cancer drug in China amid generic competition - Reuters
Eli Lilly transfers commercialization rights for breast cancer drug in China amid generic competition Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxOU3c5a1lGUmk5eEU2TEMzYXhydlcwNXVfdGJ5OFM0cWRJbkk2VWpPRW1zY0hyZ0dwMF9ZX2xfNE9zR3NyNEJfVmJVRFp4X3FVRDZoQU83RDUyc1pwQjBxS2gtM1RjVTg3VE1zbWZtME9ZSEdKcW9sRmxqWlUwRGlRVXEzSE00WHRMS0FseUVwZEZaYkdHSjZpTnpsS21ncHV4Skc5T2JhWWViYld6Y0NtbGNoajJUV2pSMjdWaExxcEN6MFA2M1Bnd1FvRDNEdw?oc=5" target="_blank">Eli Lilly transfers commercialization rights for breast cancer drug in China amid generic competition</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Lawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMNovo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com
Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com
August 13, 2026 at 10:02 AMUS FDA approves Bristol Myers' blood cancer treatment - Reuters
US FDA approves Bristol Myers' blood cancer treatment Reuters
August 13, 2026 at 09:33 PMModerna, Merck breakthrough could usher in wave of cancer vaccines - Reuters
Moderna, Merck breakthrough could usher in wave of cancer vaccines Reuters
August 19, 2026 at 09:01 PMLilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com
August 12, 2026 at 10:27 AMModerna shares double as cancer vaccine data rekindles investor hopes - Reuters
Moderna shares double as cancer vaccine data rekindles investor hopes Reuters
August 19, 2026 at 04:49 PM